# Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

> **NCT02600208** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Julie-An M. Talano** · enrollment: 60 (estimated)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DEVICE:** CliniMACs

## Key facts

- **NCT ID:** NCT02600208
- **Lead sponsor:** Julie-An M. Talano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-10
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600208, "Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02600208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*